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Nef proteins of primate lentiviruses promote viral replication, virion infectivity, and evasion of antiviral
immune responses by modulating signal transduction pathways and downregulating expression of receptors at
the cell surface that are important for efficient antigen-specific responses, such as CD4, CD28, T-cell antigen
receptor, and class I and class II major histocompatibility complex. Here we show that Nef proteins from
diverse groups of primate lentiviruses which do not require the chemokine receptor CXCR4 for entry into
target cells strongly downmodulate the cell surface expression of CXCR4. In contrast, all human immunode-
ficiency virus type 1 (HIV-1) and the majority of HIV-2 Nef proteins tested did not have such strong effects.
SIVmac239 Nef strongly inhibited lymphocyte migration to CXCR4 ligand, the chemokine stromal derived
factor 1 (SDF-1). SIVmac239 Nef downregulated CXCR4 by accelerating the rate of its endocytosis. Down-
modulation of CXCR4 was abolished by mutations that disrupt the constitutively strong AP-2 clathrin adaptor
binding element located in the N-terminal region of the Nef molecule, suggesting that Nef accelerates CXCR4
endocytosis via an AP-2-dependent pathway. Together, these results point to CXCR4 as playing an important
role in simian immunodeficiency virus and possibly also HIV-2 persistence in vivo that is unrelated to viral
entry into target cells. We speculate that Nef targets CXCR4 to disrupt ordered trafficking of infected
leukocytes between local microenvironments in order to facilitate their dissemination and/or impair the
antiviral immune response.
Chemokine receptors mediate cell responses to chemokines,
a family of polypeptides that regulate leukocyte migration and
activation (30, 44). Many chemokines are proinflamatory cyto-
kines induced to attract leukocytes mediating inflammatory
reactions. Some chemokines, such as stromal derived factor 1
(SDF-1), also perform other basic functions in the immune
system, which are not directly related to the inflammatory
functions, such as regulating the trafficking of immature blood
cells and naı¨ve lymphocytes (2, 34). Ordered movement of
leukocytes between specific sites within lymphoid tissue and
eventually to sites of inflammation is required for normal de-
velopment of the lymphoid compartment as well as for the
development and maturation of the immune response (45).
Chemokine receptors, in conjunction with CD4, are also
essential for the entry of primate lentiviruses into their target
cells (18, 20). Simian immunodeficiency virus (SIV), human
immunodeficiency virus type 1 (HIV-1), and human immuno-
deficiency virus type 2 (HIV-2) use overlapping yet distinct sets
of chemokine receptors as entry cofactors (8). HIV-1 strains
that prevail during the early course of infection usually use
CCR5 chemokine receptor (6) while those isolated from AIDS
patients frequently use CXCR4 or are dual tropic for CCR5
and CXCR4 (70). HIV-2 strains are relatively promiscuous in
their use of chemokine coreceptors. They frequently use
CXCR4, but other receptors such as CCR5, STRL33 (Bonzo),
and GPR-15 (Bob) often support viral infection (55). SIV-
mac239 and SIVsm strains, which are closely related to HIV-2,
use monkey and human CCR5 (13, 37, 41). The role of
STRL33 for infection of primary cells by these strains is un-
clear (53). Notably, SIVmac239 and SIVsm strains do not use
CXCR4 as an entry cofactor (13, 43, 69).
The accessory protein Nef is an important virulence factor of
primate lentiviruses (17, 33, 36). Nef proteins modify cellular
environments so that they become more conducive for viral
replication. They also facilitate immune evasion of the infected
cells by modulating signal transduction pathways and down-
regulating cell surface receptors that are important for antigen
presentation and for antigen-specific responses. SIV and
HIV-1 Nef proteins share many functions, including the abil-
ities to downmodulate cell surface CD4, CD28, and class I and
class II major histocompatibility complex (MHC) by acceler-
ating their endocytosis rates and possibly by blocking their
transit to the plasma membrane (1, 4, 5, 23, 24, 32, 59, 61, 64,
66, 67). They also share the abilities to associate with the
regulators and effectors of the small GTPase Rac, such as
DOCK2-ELMO1 complex and p21-activated kinase 2 (PAK-2)
(29, 38, 56). Despite these similarities, important differences
exist between the functions of SIV and HIV-1 Nef proteins.
For example, SIVmac239 and HIV-2 Nef proteins strongly
downmodulate the T-cell antigen receptor-CD3 complex while
HIV-1 Nef does not have such an effect (3, 27).
Nef proteins downmodulate cell surface expression of CD4,
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CD28, and T-cell receptor-CD3 by recruiting these receptors
to sites of the AP-2 clathrin-adaptor-dependent endocytosis
(16, 24, 40, 51, 67, 68). Observations from structural and bio-
chemical studies indicate that this involves formation of trim-
eric complexes where Nef, the target receptor, and AP-2 bind
each other cooperatively (11, 16, 26, 40, 54, 68). SIVmac239
Nef possesses two constitutively strong AP-2 binding determi-
nants in its N-terminal region (40). It uses the N-distal AP-2
binding determinant to bind AP-2 in the context of CD4 and
CD28 (40, 67). In contrast, another Nef surface is required for
cooperative binding of the SIV Nef-CD3 complex to AP-2
(68). The use of distinct AP-2 interaction surfaces of Nef to
recruit different membrane receptors provides a mechanism
for independent and specific selection of distinct types of target
receptors and their recruitment to AP-2 for endocytosis. Class
I MHC complexes are downregulated by an AP-2 independent
mechanism(s) (9, 25, 39, 52).
Previous studies revealed that an HIV-1 nef allele inhibited
SDF-1-induced migration of Jurkat T cells and of primary
human CD4 T lymphocytes without affecting CXCR4 expres-
sion at the cell surface (14). Additionally, we reported that a
different, patient-derived HIV-1 nef allele (NA7) disrupts mi-
gration to SDF-1 by hyperactivating a Rho-family GTPase Rac
through the DOCK2-ELMO1 guanine exchange factor, which
signals downstream of chemokine receptors (21) and is bound
by Nef (29). Importantly, though we found that NA7 Nef
slightly lowers the cell surface expression of the SDF-1 che-
mokine receptor CXCR4, this effect in and of itself cannot
account for the observed perturbations of HIV-1 Nef-induced
lymphocyte migration (29).
Here we show that lymphocyte migration to SDF-1 is also
strongly inhibited by SIVmac239 Nef. Furthermore, Nef pro-
teins encoded by diverse SIV strains strongly downregulate the
cell surface expression of CXCR4 by accelerating its endocy-
tosis. In contrast, HIV-1 and the majority of HIV-2 Nef pro-
teins tested did not have such strong effects. Since SIVmac239
and other SIV strains usually do not use CXCR4 as an entry
cofactor, our observations suggest that Nef targets CXCR4-
controlled processes to inhibit the physiological role(s) of this
chemokine receptor.
MATERIALS AND METHODS
Plasmids. HIV-1, HIV-2, and SIV nef alleles and mutants were subcloned
downstream of the cytomegalovirus promoter into the pCGCG bicistronic vector
(40). The same transcription unit also contains the green fluorescent protein
(GFP) gene under the translational control of the encephalomyocarditis virus
internal ribosome entry site (IRES). The SIVmac239 nef mutants 239(31–37),
239(64–67), 239(23–74), 239(LM194AA), 239(LL20AA), 239(P104A,P107A), 239(RR137AA),
239(DD88NN,E*DDD91NQNNN) (Aci1), 239(Y223F), 239(Y28A,Y39A) and HIV-1 NA7
and SF2 nef genes were described previously (28, 40, 42, 66, 68). Bicistronic
pCGCG vectors coexpressing GFP and the HIV-2 ROD, HIV-2 BEN, HIV-1
Priso-k1, 93BRO29k1, and 13127K2 nef alleles were described previously (38,
59).
The HIV-2 CBL23 (60) nef was PCR amplified using primers HIV2Xba1,
5-CGGTCTAGATGCAATATGGGTGCGAG-3, and pHIV-2MluI, 5-
CCACGCGTTAACTAAATGGTATTCCT-3. The remaining HIV-2 nef genes
were amplified from the CDC 310319 and 60415K strains (22, 48) obtained from
Mark Rayfield, Stephen Wiktor, Feng Gao, and Beatrice Hahn through the
AIDS Research and Reference Reagent Program, Division of AIDS, National
Institutes of Health (46). The primers were pHIV2Xba10319, 5-CGGTCTA
GATGGGATCAGCTGGTTC-3, or pHIV260415KXba, 5-CGGTCTAGAT
GGGTGCGAGTGGAT-3, paired with either p310319Mlu, 5-GTACGC
GTCTAATCTGTTGGTATTCCCCTT-3, or p60415KMlu, 5-GTACGCGTT
TAATTAAATGGTATTCCT-3.
The SIVsm FWr nef allele was amplified by nested PCR with the inner primers
pSIVsmXba, 5-ACCTATCTAGAGCCCTTATGGGTGGCGTTACC-3, and
SIVsm(MluI), 5-GTCCCTACGCGTCAGCTTGTTTCCTTCTTG-3, from the
blood of a naturally infected sooty mangabey, kindly provided by Francis No-
vembre. Five to six individual nef clones per SIVsm or HIV-2 sample were
sequenced and one representative allele was selected for functional analyses.
SIVcne5 and SIVblu31 nef clones were kindly provided by Beatrice Hahn and
Frederic Bibollet-Ruche. The nef genes were amplified with pSIVcne5XbaI,
5-TCTGGGTCTAGAG-TCAATATGGGTGGAAAG-3, paired with
pSHIVcne5Mlu, 5-CGGTTAACGCGTCTACTTCCTCTTAGGGAACAT-3,
and pSIVblu3.1XbaI, 5-TCTGTGTCTAGATCGGCTATGGGTTCCACG-3,
together with pSHIVblu3.1MluI, 5-CTAGGAACGCGTCTACTTAAGTGCT
GACTTTGA-3, respectively.
The full-length pSAB-1 (31) and pSIVagmTAN-1 (63) molecular clones were
obtained from Mojun Jin, Marcelo Soares, and Beatrice Hahn through the AIDS
Research and Reference Reagent Program, Division of AIDS. The nef alleles
were PCR amplified using SIVagmsabXbaI, 5-TCCTCTAGATACAATAT
GGGTGGCAAGAGCTCAA-3, SIVagmsabMluI, 5-TGCACGCGTTCAG
GCAGACACTGACGGCAC-3, and SIVagmtanXbaI, 5-GCCTCTAGAT
TCAGTATGGGTGGCAGCAATTCAA-3, together with SIVagmtanMluI, 5-
GCGACGCGTCTACTTCCTCTTAACAAGACCATGC-3. All primers intro-
duced XbaI and MluI restriction sites flanking the nef gene for cloning into the
bicistronic pCGCG vector. Rhesus CXCR4 cDNA was cloned between XbaI and
MluI restriction sites in pCGCG bicistronic vector.
Cells and transfections. Jurkat T cells (JJK) expressing human CD4 at a high
level were maintained in RPMI 1640 medium supplemented with 2 mM glu-
tamine and 15 mM HEPES, pH 7.4, and cultures were diluted 1:10 every 3 to 4
days (28). Aliquots of 107 Jurkat T cells from exponentially growing cultures were
electroporated at 200 V and 960 F with 20 g of an appropriate expression
vector as described (28). HEK 293T cells and CV1 cells were maintained and
transfected as described previously (29, 66).
Proviruses and infections. SIVmac239 nef IRES-GFP and SIVmac239 nef
IRES-GFP each contain the IRES-EGFP cassette immediately downstream of
the nef gene and were provided by Jan Mu¨nch. env-defective variants of the
above proviruses were generated by filling in a unique ClaI site located in env
coding sequence immediately downstream of arginine codon R491 and thereby
creating a frameshift mutation at this site. Vesicular stomatitis virus G
pseudotyped viral stocks were produced from HEK 293T cells cotransfected with
SIVmac proviral constructs carrying either nef open or nef-defective reading
frames, followed by IRES-GFP, and a plasmid expressing Env protein of the
vesicular stomatitis virus. Viral stocks were stored frozen at86°C. Jurkat T cells
were transduced with the pseudotyped virus particles, and cell surface expression
of CXCR4, CD4, CD3, CD28, and class I MHC on GFP-expressing cells was
analyzed 3 days later by flow cytometry.
Flow cytometry. Aliquots of 3  105 cells were washed once with phosphate-
buffered saline (PBS) containing 1% fetal bovine serum and 0.1% sodium azide
(PBS-FA). Cells were reacted at 4°C with 50 l aliquots of PBS-FA containing
saturating amounts of phycoerythrin-conjugated monoclonal antibodies specific
for CXCR4 (12G5, BD Pharmingen), CD4 (SK3, BD Pharmingen), CD28
(CD28.2, BD Pharmingen), class I MHC (W6/32, BD Pharmingen), or CD3ε
(HIT3A, BD Pharmingen), washed twice with PBS-FA, and suspended in 200 l
PBS-FA, and receptor expression and GFP expression were analyzed on an
LSR-II flow cytometer (Becton Dickinson). Cells infected with SIV-derived
vectors were fixed with 3% paraformaldehyde following staining and analyzed by
flow cytometry.
Endocytosis assays. Jurkat T cells coexpressing Nef and GFP from bicistronic
pCGCG vectors or expressing GFP alone as a negative control were used.
Internalization rates of CXCR4 and CD4 from the cell surface were measured by
flow cytometry as previously described (26, 66, 68). Briefly, 12 to 16 h after
transfection cells were reacted with saturating amounts of phycoerythrin-conju-
gated monoclonal antibodies specific for CXCR4, or CD4, in RPMI 1640 me-
dium containing 0.2% bovine serum albumin and 10 mM HEPES (pH 7.4) on ice
for 20 min. Cells were then washed to remove the unbound antibody, and
aliquots of 105 cells were incubated at 37°C to allow receptor internalization. The
incubations were terminated on ice and each sample was divided into two
aliquots. One aliquot was diluted fivefold with PBS to measure total cell surface
receptor. The other aliquot was also diluted fivefold with RPMI 1640 adjusted to
pH 2 to remove monoclonal antibody that had not been internalized. This
permitted us to determine specifically the internalized receptor. Total and in-
ternalized receptors were determined by flow cytometry for cells showing iden-
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tical levels of GFP expression. The fraction of receptor internalized was calcu-
lated as described previously (67, 68).
Migration assays. Jurkat T cells were transfected by electroporation with
plasmids coexpressing Nef and GFP marker protein from a single bicistronic
transcription unit (pCGCG) (40); 24 to 48 h later the transfected cells were
washed once in RPMI 1640 supplemented with 1% bovine serum albumin
(RPMI/BSA), resuspended in RPMI/BSA at 1.5  107 per ml, incubated for 1 h
in a CO2 incubator and 100-l aliquots of cell suspensions were applied to upper
chambers of 24-well Trans-Well plates (Costar 3421), and 450 l of RPMI/BSA
supplemented with 10 ng/ml SDF-1 (R&D Systems) was loaded into the lower
chambers. Cells were allowed to migrate for 2 h, and the relative frequencies of
GFP-positive cells in the initial and migrated populations were determined by
using an LSR-II flow cytometer (Becton Dickinson). For each GFP-fluorescence
gate the fraction of migrated cells was calculated by dividing the fraction of cells
found in that gate in the migrated population by that in the initial population of
cells (29).
RESULTS
A transient expression assay in human Jurkat T cells was
used to study the effect of SIV Nef and HIV Nef on CXCR4
cell surface expression. Cells were transfected with plasmids
expressing Nef and a GFP reporter protein from the same
bicistronic transcription unit and CXCR4 expression and GFP
expression were detected by flow cytometry. As shown in Fig.
1A, expression of SIVmac239 Nef (SIVmac239 Nef) resulted
in a dose-dependent decrease in CXCR4 expression on the cell
surface. In contrast, expression of HIV-1 Nef protein encoded
by the NA7 allele had a diminished effect on CXCR4 cell
surface levels, in agreement with previous observations (29).
To confirm that CXCR4 is downregulated in virally infected
cells, we characterized its expression on the surface of cells
expressing the SIVmac239 provirus. As controls, we also mea-
sured cell surface expression of CD4, CD3, CD28 and class I
MHC, which are all downmodulated by SIVmac239 Nef (3, 4,
5, 39, 67). To directly visualize the productively infected cells
we used viral constructs expressing GFP from an IRES ele-
ment placed immediately downstream of the nef gene. The
viruses also carried a frameshift mutation in the env gene to
permit only a single infection cycle. Viral stocks pseudotyped
with Env protein of the vesicular stomatitis virus (vesicular
stomatitis virus G) were produced from HEK 293T cells co-
transfected with proviral constructs carrying either the nef
open or nef-defective reading frame and a plasmid expressing
vesicular stomatitis virus G and were then used to infect CD4-
positive Jurkat T cells. As shown in Fig. 1B, CXCR4 was
strongly downregulated from the surface of cells infected with
viruses containing only the intact nef gene. We also found that
SIVmac239 Nef also downregulated rhesus CXCR4 in tran-
sient expression assays in monkey CV1 cells (data not shown).
We concluded that SIVmac239 Nef strongly downregulates
cell surface expression of CXCR4 receptor for SDF-1 chemo-
kine in infected cells.
The observation that SIVmac239 Nef strongly downregu-
lates CXCR4 but HIV-1 NA7 Nef does not suggested that the
NA7 allele may be an exceptional loss-of-function allele. Al-
ternatively, it was possible that the ability to downregulate
CXCR4 is conserved only in Nef proteins from a certain subset
of primate lentiviruses. To distinguish between these possibil-
ities we tested additional SIV and HIV-1 Nef proteins for their
ability to downregulate CXCR4 from the cell surface. We also
characterized Nef proteins from several HIV-2 strains. HIV-2
is closely related to SIVmac yet it frequently uses CXCR4 as an
entry coreceptor, while SIVmac does not (13, 43, 69). We also
characterized the abilities of all Nef proteins tested to down-
modulate CD4, since this function is known to be widespread
among lentiviral Nef and therefore this assay could identify
generally inactive proteins.
As shown in Fig. 2, all SIV nef alleles tested downmodulated
CXCR4. Nef protein encoded by SIV naturally infecting sooty
mangabeys (SIVsm, FWR1), which is closely related to
SIVmac239, caused a strong decrease in CXCR4 surface ex-
pression. This decrease was comparable to that seen with the
SIVmac239 protein. Nef proteins of two SIV strains isolated
from African green monkeys (Cercopithecus aethiops, SIVagm,
Sab1, and Tan1) had similar effects even though SIVagm is
only distantly related to SIVmac and SIVsm. Nef proteins of
SIV isolated from De Brazza’s monkey (Cercopithecus neglec-
tus, SIVcne5) (7) and from blue monkeys (Cercopithecus mitis,
SIVblu31) also downmodulated CXCR4, but their effects were
not as strong as those seen with SIVmac-, SIVsm-, and
SIVagm-derived alleles. Additional SIVcne and SIVblu Nef
proteins need to be characterized to determine whether the
alleles tested are representative or rather unusual weak alleles.
The effects of HIV-2 Nef proteins on CXCR4 cell surface
expression were somewhat less pronounced. Of five alleles
tested only the Ben allele decreased CXCR4 expression to
levels seen with SIVmac- and SIVsm-derived nef genes. The
remaining four HIV-2 nef alleles also diminished cell surface
CXCR4 expression but to lesser extents. Finally, all six HIV-1
nef alleles tested affected CXCR4 cell surface expression but
only marginally. We concluded that Nef proteins from diverse
SIV strains strongly downregulate CXCR4, those from HIV-1
do so weakly, and those from HIV-2 have intermediate effects.
In contrast, all Nef proteins tested strongly downregulated cell
surface expression of CD4. Clearly, there was no correlation
between the ability of various Nef proteins to downregulate
CXCR4 and CD4.
Nef proteins downmodulate cell surface levels of target re-
ceptors by recruiting them to sites of endocytosis (9, 24, 38, 51,
61, 67). Therefore we asked whether SIVmac239 Nef enhances
CXCR4 endocytosis rate. Jurkat T cells were transfected to
transiently express SIVmac239 Nef or HIV-1 NA7 Nef and
GFP or GFP alone as controls. Cells were reacted with anti-
CXCR4 monoclonal antibody labeled with phycoerythrin. Sub-
sequently, the rates of CXCR4 internalization in Nef-express-
ing and in control cells were determined for populations
showing identical levels of GFP fluorescence using a flow cy-
tometry-based endocytosis assay (67, 68). As a control, we
determined the rates of CD4 endocytosis in the same trans-
fected cell populations.
As shown in Fig. 3, expression of SIVmac239 Nef resulted in
an approximately 10-fold increase in the rate of CXCR4 inter-
nalization over that seen in cells expressing GFP protein alone.
The magnitude of this increase was almost as high as that seen
for CD4 in cells expressing SIVmac239 and HIV-1 NA7 Nef
proteins. Thus, the accelerated endocytosis of CXCR4 was
probably responsible for its downregulation from the surface of
SIVmac239 Nef-expressing cells. Notably, HIV-1 Nef also in-
creased the CXCR4 endocytosis rate compared to that in con-
trol cells, but to a much lesser extent than SIVmac239 Nef.
This is consistent with the observations that the NA7 Nef
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modestly decreased CXCR4 cell surface expression and likely
explains this phenomenon (Fig. 1A and 2A) (29).
To elucidate how SIVmac239 Nef induces CXCR4 endocy-
tosis, we studied which surfaces and elements of the protein
are required for this effect. Previous studies revealed that SIV
Nef induces endocytosis of CD4, CD28, and CD3 via the AP-2
clathrin adaptor pathway and class I MHC via an AP-2-inde-
pendent pathway (40, 66–68). Mutations in SIVmac239 Nef
that selectively disrupt molecular interactions required for
these different functions were previously identified (40, 51, 67,
68). Therefore we tested the effects of these mutations on the
ability of SIVmac239 Nef to downregulate CXCR4 cell surface
expression. Figure 4 shows the results of these experiments.
We first tested a mutation that disrupts the interaction of
SIVmac239 Nef with the AP-2 clathrin adaptor by deleting two
constitutively strong AP-2 binding elements located in the N-
terminal region of this Nef molecule (23–74) (40). As shown
in Fig. 4, this mutation severely disrupted CXCR4 downregu-
lation (Fig. 4, panel 9). Next we tested two smaller deletions in
the same region that each removes a different constitutively
strong AP-2 binding element in Nef (40). Deletion of amino
acid residues including lysine L31 through aspartic acid D37
(31–37) removes the N-proximal AP-2 binding element that
is dispensable for known functions of Nef (40, 68). This mu-
tation had a weak disruptive effect on the ability of Nef to
downregulate CXCR4 (Fig. 4, panel 13). A more limited dis-
ruption of this region by alanine substitutions for tyrosines Y28
and Y39, which were implicated as important for the interac-
tion with the 2 subunit of the AP-2 complex (51), had no
detectable effect on downregulation of CXCR4 or any of the
other receptors tested (Fig. 4, panels 45 to 48). Thus, another
aspect of the N-proximal element likely contributes to CXCR4
downregulation.
Deletion of amino acids Q64 to N67 (64–67) removes the
N-distal AP-2 binding element in SIVmac239 Nef, which is
required for downregulation of CD4 and CD28 through their
recruitment to AP-2. Notably, the 64–67 mutation severely
disrupted the ability of Nef to downregulate cell surface
CXCR4 (Fig. 4, panel 17). This observation further suggested
that Nef uses the N-distal element to downregulate CXCR4
through the AP-2 mechanism, similar to how it downregulates
CD4 and CD28 (40, 67) (data not shown).
Then we analyzed additional mutations in Nef that compro-
mise CD4 downregulation and/or other Nef functions. Initially
we focused on mutations that do not affect constitutively strong
Nef binding to AP-2 but rather disrupt other molecular inter-
actions required for CD4 downregulation (40). Alanine substi-
tutions for leucine L194 and methionine M195 (LM194AA)
selectively diminished CXCR4 and CD4 downregulation with-
out affecting T-cell receptor-CD3 and class I MHC cell surface
expression (Fig. 4, panels 25, 27, and 28). Mutation in acidic
element (Aci1, residues D88 to D95) (12) disrupted in part the
effect of Nef on CXCR4 (Fig. 4, panel 29). This mutation was
shown previously (28, 67) to have a pleiotropic effect on several
Nef functions including CD4 and class I MHC downregulation
(Fig. 4, panels 30 and 32). The mutation of the arginine resi-
dues R137 and R138 (RR137GG) also had a pleiotropic effect
on receptor expression but had little detectable effect on
CXCR4 downregulation (Fig. 4, panel 37). Similarly, two mu-
tations that selectively disrupted downregulation of class I
FIG. 1. SIVmac239 Nef downregulates CXCR4 cell surface expres-
sion. (A) Flow cytometry analysis of CXCR4 and GFP expression in
Jurkat T cells transiently coexpressing SIVmac239 or HIV-1 NA7 Nef
and GFP reporter from bicistronic transcription units (panels 2 and 3).
Cells expressing GFP alone were used as a negative control (panel 1,
mock). (B) Flow cytometry analysis of CXCR4, CD4, CD3, CD28 and
MHC I cell surface expression in Jurkat T cells infected with vesicular
stomatitis virus G pseudotyped SIVmac239 containing a wild type
(nef, panels 6 to 10) or inactive (nef, panels 1 to 5) nef gene, and a
GFP reporter. Histograms of cell surface expression of the receptors
for populations of cells infected with nef SIV (light gray), nef SIV
(dark gray), and showing identical levels of GFP fluorescence gated as
indicated in panels 1 and 6, are also shown (panels 11 to 15). Histo-
grams for uninfected cells (thick line) and unstained cells (thin line)
are included as positive and negative controls for receptor expression.
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FIG. 2. Effects of SIV, HIV-1 and HIV-2 Nef proteins on CXCR4 and CD4 cell surface expression. (A) Flow cytometry analysis of CXCR4
and CD4 expression on the surface of Jurkat T cells transiently transfected to coexpress the indicated Nef proteins and GFP marker from
bicistronic expression vectors. Cells expressing GFP alone were used as a negative control (mock). (B) CXCR4 and CD4 downregulation by Nef
proteins. For each Nef protein tested in A, a mean level of CXCR4 (left) and CD4 (right) on the surface of positively transfected cells is shown.
The analysis was performed for positively transfected cell populations gated for a narrow range of GFP expression as indicated in the upper
leftmost panels in A.
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MHC (LL20AA and Y223A) (67) had little detectable effect
on CXCR4 downregulation (Fig. 4, panels 21 and 41).
Finally, alanine substitutions for prolines P104 and P107,
which in HIV-1 Nef are required for association with PAK2
kinase (58), did not have a noticeable effect on the downregu-
lation of any of the four receptors under study (Fig. 4, panel 33
to 36). Together, these data are consistent with the possibility
that the ability of SIVmac239 Nef to bind AP-2 via its N-distal
AP-2 binding element is crucial for CXCR4 downregulation
and support the possibility that Nef induces CXCR4 endocy-
tosis via the AP-2 clathrin adaptor.
CXCR4 mediates migration of cells to SDF-1 chemokine
(10, 47). Since CXCR4 levels on the surface of SIVmac239
Nef-expressing cells were at least 10-fold lower than those on
control cells, we characterized the migration of these cells to
SDF-1. Jurkat T cells were transiently transfected with a con-
trol plasmid expressing GFP marker protein alone or with a
plasmid that coexpresses Nef and a GFP marker protein from
the same bicistronic transcription unit. Migration of the cell
populations to SDF-1 was measured using a Transwell migra-
tion assay. The relative frequency of Nef-expressing and con-
trol cells in the migrated populations was then determined by
flow cytometric measurement of GFP fluorescence (29).
Consistent with previous observations, approximately 30%
of cells in the control populations migrated regardless of the
level of GFP expression (29, data not shown). In contrast, in
cell populations expressing SIVmac239 Nef migration was in-
hibited with increasing Nef/GFP expression in a dose depen-
dent manner up to 100-fold (Fig. 5). Notably, the SIV Nef was
more potent in inhibiting SDF-1-induced migration than
HIV-1 Nef. We showed previously that inhibition of lympho-
cyte migration by HIV-1 NA7 Nef is independent of a slight
decrease in CXCR4 expression levels seen on the surface of
cells expressing this Nef protein (29). These observations to-
gether suggested that strong downmodulation of CXCR4 cell
surface expression is an important component to the SIV-
mac239 induced inhibition of migration to SDF-1.
To demonstrate this directly we determined effects of mu-
tations in SIVmac239 Nef that disrupted CXCR4 downmodu-
lation on the inhibition of migration to SDF-1. The results are
shown in Fig. 5 in a scatter plot as a function of CXCR4
expression levels on the surface of the transfected cell popu-
lations. Mutations such as 64–67, 23–74, Aci1, and
LM194AA severely diminished the ability of SIVmac239 Nef
to downmodulate CXCR4. All these mutations also severely
disrupted the ability of SIVmac239 Nef to inhibit cell migra-
tion to SDF-1. Mutations such as LL20AA, 31–37,
RR137GG, and Y223A disrupted CXCR4 downmodulation by
SIVmac239 Nef to a lesser extent. However, these mutations
had only a marginally negative effect on the ability of SIV-
mac239 Nef to inhibit lymphocyte migration to SDF-1. Thus,
generally there was a strong positive correlation between the
ability of mutant Nef proteins to downmodulate CXCR4 and
to inhibit SDF-1-induced lymphocyte migration (Pearson cor-
relation coefficient r  0.93, P  0.0001).
Interestingly, a closer examination of the data revealed that
the Nef variant carrying the Y223A mutation inhibited migra-
tion more strongly than the wild-type SIVmac239 Nef even
though the effect of the two proteins on CXCR4 expression
was comparable. Therefore the robust disruption of lympho-
cyte migration to SDF-1 cannot be explained only by the ability
of SIV Nef to downmodulate CXCR4, and additional compo-
nents that contribute to this effect likely exist.
DISCUSSION
We report that Nef proteins encoded by several SIV strains
strongly decrease expression of the CXCR4 chemokine recep-
tor from the cell surface and that the HIV-2 Ben Nef had a
similar strong effect. This effect requires the N-distal constitu-
tively strong AP-2 binding determinant in the amino-terminal
region of SIVmac239 Nef. The N-distal element is also critical
for the ability of SIVmac239 Nef to recruit CD4 and CD28 to
the AP-2 clathrin adaptor for endocytosis (40, 67). The above
observations as well as evidence discussed below support the
possibility that Nef induces CXCR4 endocytosis via the AP-2
clathrin adaptor. Notably, CXCR4 and CD4 contain in their
cytoplasmic domains similar phorbol ester-activated endocyto-
sis signals that are reactive with the AP-2 clathrin adaptor.
These signals contain either a dileucine or leucine-isoleucine
motif and are activated by phosphorylation of a serine residue
located in its vicinity (62). Furthermore, CXCR4 undergoes
slow constitutive internalization through coated pits and
coated vesicles into the endosomal compartment from which it
can recycle back to the cell surface, similar to CD4 (50, 62).
Finally, both constitutive and Nef-induced CD4 and/or CD28
internalization occurs via the AP-2/coated-pits pathway (24,
49, 51, 67). Thus, the possibility that Nef induces CXCR4
endocytosis via the AP-2 clathrin adaptors is consistent with
the general model wherein Nef downregulates target receptors
by exploiting the same mechanisms that mediate their inter-
nalization under physiologic conditions.
The observation that Nef proteins of diverse SIV and HIV-2
strains specifically downregulate CXCR4 indicates that this
function is important for effective viral persistence in the host.
Notably, the ability of Nef to decrease CXCR4 cell surface
expression does not appear to correlate with the ability of these
strains to use CXCR4 as coreceptor for entry. For example,
SIVmac and SIVsm do not use CXCR4 and strongly diminish
CXCR4 cell surface expression (13). Conversely, HIV-2 Ben
virus uses CXCR4 (35) (data not shown), yet the Nef protein
it encodes strongly downregulates CXCR4. Additionally, Nef
proteins specified by HIV-1 strains, which frequently utilize
FIG. 3. SIVmac239 Nef accelerates CXCR4 endocytosis rate. The
rates of CXCR4 endocytosis (left panel) and CD4 endocytosis in
Jurkat T cells expressing SIVmac239 Nef (E), HIV-1 NA7 Nef (),
and control cells (‚) were measured by a flow cytometry-based endo-
cytosis assay. The percentage of CXCR4 internalized from the cell
surface is shown as a function of time.
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FIG. 4. Effects of mutations in SIVmac239 Nef on downregulation of CXCR4 and other cell surface receptors. Flow cytometry analysis of
CXCR4, CD4, CD3, and class I MHC expression on the surface of Jurkat T cells transiently expressing the indicated Nef proteins and GFP marker
from bicistronic expression vectors. Cells expressing GFP alone were used as a negative control (mock).
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CXCR4, are generally unable to strongly decrease cell surface
CXCR4. Together this evidence points to CXCR4 having an
important role for SIV and possibly also HIV-2 replication in
vivo and suggests that this function is unrelated to viral entry
into the target cells. Notably, we observed that SIVsm Nef
downregulates CXCR4 just as strongly as SIVmac Nef. Since
SIVsm replicates to high titers in sooty mangabeys, its natural
host, but the infection is generally apathogenic (57), CXCR4
downregulation by Nef and the resulting migration defects are
probably insufficient for the pathogenesis of lentiviral infec-
tions and have no apparent global immunosuppressive effects.
HIV-1 Nef proteins do not downregulate CXCR4 yet also
inhibit lymphocyte migration to SDF-1 (14, 29). This effect is
mediated by activation of Rac2 and/or Rac1 by the DOCK2-
ELMO1 guanine exchange factor to which Nef binds (29).
Notably, SIVmac239 Nef appeared to be a more potent inhib-
itor of lymphocyte migration to SDF-1 than HIV-1 Nef vari-
ants tested so far. Our data revealed that the robust effect of
SIVmac Nef on chemotaxis correlated with its ability to down-
regulate CXCR4. SIVmac239 Nef also binds DOCK2-ELMO1
and activates Rac (data not shown). Thus, this mechanism may
also contribute to the blocking of lymphocyte migration by
SIVmac239 Nef.
SDF-1, through CXCR4, regulates multiple aspects of lym-
phocyte trafficking during the development and generation of
the immune response (2, 15, 34). Experiments with SDF-1 and
CXCR4 knockout mice revealed that SDF-1 promotes lym-
phocyte retention in lymphoid tissue, thereby preventing exit
to the vasculature. Induction of transendothelial migration of
diverse types of lymphocytes to lymph nodes and Peyer’s
patches is another important function of SDF-1, which also
directs lymphocyte migration in extravascular tissues. Through
such actions, SDF-1 and other chemokines recruit lymphocytes
to specific compartments in the lymphoid tissue. These events
are crucial for the proper coordination of the immune re-
sponse.
The possibility that Nef indeed disrupts the trafficking of the
infected T cells in vivo is consistent with the observations from
recent studies localizing T cells containing actively replicating
SIV in lymph nodes from rhesus monkeys inoculated with
either wild type or delta-nef SIVmac239 virus (65). In animals
infected with wild-type SIVmac239, most of the infected T cells
were located in the T-cell-rich paracortex. In contrast, in ani-
mals infected with the nef virus, most were localized in B-cell-
rich follicles and in the border region between the paracortex
and the follicles. These differences were previously taken as
evidence for the ability of Nef to activate T cells in the para-
cortex (65). However, they are also consistent with the possi-
bility that the ability of the infected Nef-expressing T cells to
respond to chemotactic cues that would normally direct them
to B-cell follicles is suppressed. It will be important to under-
stand whether this mislocalization results from Nef-disrupted
migration of the infected T lymphocytes and to determine the
scenarios in which Nef-mediated inhibition of infected leuko-
cytes to SDF-1 occurs.
How CXCR4 downregulation in infected cells provides a
selectable advantage for the virus is presently not known.
Nonetheless, possible explanations are suggested by the known
functions of SDF-1. One likely scenario is based on the fact
that the fine tuning of leukocyte traffic through secondary
lymphoid tissues by chemokines is essential for efficient im-
mune surveillance and for the development of the immune
response. Notably, in HIV-1 infection, a large fraction of HIV-
1-infected CD4 T cells are specific for HIV-1 antigens (19).
Thus, disrupting lymphocyte traffic could provide yet another
means to interfere with the development of the immune re-
sponse to SIV antigens. Another scenario is suggested by the
observation that SDF-1 can promote lymphocyte retention at
local sites. Disruption of such cues could promote the exit of
the infected T cells from the secondary lymphoid organs to the
periphery and thus facilitate their dissemination throughout
the immune system. Finally, it is conceivable that under some
conditions, SDF-1-induced CXCR4 signaling could negatively
affect SIV replication by means that are not related to lym-
phocyte migration. Future studies should focus on how
CXCR4 downregulation by Nef provides those primate lenti-
viruses that do not use CXCR4 as an entry cofactor with a
selectable advantage in the infected host.
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